Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
www.cnbc.com
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
    • return2ozma@lemmy.worldOP
      11·
      5 months ago

      We currently have Pre-Exposure Prophylaxis (PrEP) which is a daily pill that’s 99% effective at preventing HIV. Only having to do 2 shots a year would be a lot better than remembering a daily pill.